Moderna asks investors to wait for full data on flu vaccine amid selloff

Published by

By Leroy Leo and Mrinalika Roy (Reuters) -Moderna Inc executives called on investors to wait for more data amid a sharp selloff in its shares on Friday, after early data showed its mRNA-based flu vaccine was no better than already approved shots in the market. The company’s shares tumbled 10% after its investor presentation showed antibody levels of its vaccine against all four strains of the influenza virus in an early-stage study were not as robust in older people as Sanofi’s Fluzone HD. “We can’t make a direct comparison. We presented (Fluzone data) only as guidance,” a company executive sa…

Read More

Leave a Reply